Biofrontera AG (ETR:B8FK)
2.380
-0.090 (-3.64%)
May 29, 2026, 6:02 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €14.71 million as of May 29, 2026. Its market cap has decreased by -7.28% in one year.
Market Cap
14.71M
Enterprise Value
11.17M
Revenue
13.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.38
Market Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 14.71M, a decrease of -61.35%. That is a compound annual growth rate of -4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 14.71M | -0.82% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.30B |
| Siemens Healthineers AG | 39.04B |
| Bayer Aktiengesellschaft | 37.45B |
| Fresenius SE & Co. KGaA | 20.68B |
| DocCheck AG | 66.97M |
| Pentixapharm Holding AG | 59.48M |
| MeVis Medical Solutions AG | 42.59M |
| aap Implantate AG | 27.68M |